Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03318783
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:51.647523+00:00
Published At
2021-01-22T00:00:00+00:00
Record Updated At
2021-01-22
Results Posted At
2021-01-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Subarachnoid Hemorrhage, Aneurysmal", "Delayed Cerebral Ischemia", "Vasospasm, Cerebral", "Endothelial Dysfunction"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-01-22"
protocolSection.identificationModule.nctId
"NCT03318783"
protocolSection.identificationModule.officialTitle
"Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-01-22"

Study condition terms

  • Subarachnoid Hemorrhage, Aneurysmal (protocolSection.conditionsModule.conditions)
  • Delayed Cerebral Ischemia (protocolSection.conditionsModule.conditions)
  • Vasospasm, Cerebral (protocolSection.conditionsModule.conditions)
  • Endothelial Dysfunction (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.